These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35794204)

  • 1. Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson's disease-associated GBA gene.
    Toffoli M; Chen X; Sedlazeck FJ; Lee CY; Mullin S; Higgins A; Koletsi S; Garcia-Segura ME; Sammler E; Scholz SW; Schapira AHV; Eberle MA; Proukakis C
    Commun Biol; 2022 Jul; 5(1):670. PubMed ID: 35794204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
    Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
    Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder.
    Gámez-Valero A; Iranzo A; Serradell M; Vilas D; Santamaria J; Gaig C; Álvarez R; Ariza A; Tolosa E; Beyer K
    Parkinsonism Relat Disord; 2018 May; 50():94-98. PubMed ID: 29487000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.
    Leija-Salazar M; Sedlazeck FJ; Toffoli M; Mullin S; Mokretar K; Athanasopoulou M; Donald A; Sharma R; Hughes D; Schapira AHV; Proukakis C
    Mol Genet Genomic Med; 2019 Mar; 7(3):e564. PubMed ID: 30637984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort.
    Graham OEE; Pitcher TL; Liau Y; Miller AL; Dalrymple-Alford JC; Anderson TJ; Kennedy MA
    Parkinsonism Relat Disord; 2020 Jan; 70():36-41. PubMed ID: 31809948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
    Li Y; Sekine T; Funayama M; Li L; Yoshino H; Nishioka K; Tomiyama H; Hattori N
    Neurobiol Aging; 2014 Apr; 35(4):935.e3-8. PubMed ID: 24126159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
    Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
    Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.
    Creese B; Bell E; Johar I; Francis P; Ballard C; Aarsland D
    Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):232-241. PubMed ID: 28548708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.
    Clark LN; Chan R; Cheng R; Liu X; Park N; Parmalee N; Kisselev S; Cortes E; Torres PA; Pastores GM; Vonsattel JP; Alcalay R; Marder K; Honig LL; Fahn S; Mayeux R; Shelanski M; Di Paolo G; Lee JH
    PLoS One; 2015; 10(5):e0125204. PubMed ID: 25933391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p.
    Straniero L; Rimoldi V; Samarani M; Goldwurm S; Di Fonzo A; Krüger R; Deleidi M; Aureli M; Soldà G; Duga S; Asselta R
    Sci Rep; 2017 Oct; 7(1):12702. PubMed ID: 28983119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations.
    Arkadir D; Dinur T; Mullin S; Mehta A; Baris HN; Alcalay RN; Zimran A
    Blood Cells Mol Dis; 2018 Feb; 68():115-116. PubMed ID: 27864021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
    Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
    Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease.
    Ruskey JA; Greenbaum L; Roncière L; Alam A; Spiegelman D; Liong C; Levy OA; Waters C; Fahn S; Marder KS; Chung W; Yahalom G; Israeli-Korn S; Livneh V; Fay-Karmon T; Alcalay RN; Hassin-Baer S; Gan-Or Z
    Eur J Med Genet; 2019 Jan; 62(1):65-69. PubMed ID: 29842932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
    Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Trojanowski JQ; Schellenberg GD; Yearout D; Huston H; Fritts-Penniman A; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP
    Neurology; 2012 Nov; 79(19):1944-50. PubMed ID: 23035075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Riboldi GM; Di Fonzo AB
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and low-cost test for screening the most common Parkinson's disease-related GBA variants.
    Straniero L; Rimoldi V; Melistaccio G; Di Fonzo A; Pezzoli G; Duga S; Asselta R
    Parkinsonism Relat Disord; 2020 Nov; 80():138-141. PubMed ID: 32987361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.